Vivalyx

Vivalyx

Developer of Omnisol, an investigational perfusion solution for preserving donor organs

vivalyx.com

Soha
Biotech, MedTech
Tashkil etilgan
2022
Joylashuv
Germany

Tasdiqlangan daromad: hali ulanmagan

Vivalyx sizningmi? Ushbu sahifani soʻrang va Stripe, App Store yoki Google Play’ni ulang: MRR va oʻsishingiz shu yerda toʻgʻridan-toʻgʻri manbadan koʻrinadi.

Sizniki boʻlsa, soʻrang

Startap haqida

Vivalyx develops Omnisol, a blood-replacing perfusion solution designed to preserve and revitalise donor organs for transplantation. Omnisol is investigational and has entered first-in-human clinical use. The company is based in Aachen, Germany and is backed by Armenia-based Granatus Ventures.

Jamoa

  • Andreas Schumacher, Co-founder and CEO (Asoschi)
  • Benedict Doorschodt, Co-founder and CTO (Asoschi)
  • René Tolba, Co-founder and CMO (Asoschi)
  • Christian Bleilevens, Co-founder and CSO (Asoschi)
  • Malte Brettel, Co-founder (Asoschi)
  • Marius Rosenberg, Co-founder (Asoschi)

Auditoriya

Ijtimoiy tarmoqlardagi kuzatuvchilar

Profil maʼlumotlari manbasi: Stanbase.